At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FFTY Innovator IBD 50 ETF
Post-Mkt 09-29 17:40:44 EDT
34.90
+0.14
+0.41%
盘后34.90
+0.000.00%
16:15 EDT
High34.90Low34.69Vol5.14K
Open34.77D1 Closing34.76Amplitude0.62%
Mkt Cap80.27MTradable Cap80.27MTotal Shares2.30M
T/O179.03KT/O Rate0.22%Tradable Shares2.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time
GlobeNewswire  ·  09-29 04:05
Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time
Optical Communication Stocks Decline Broadly as Credo Technology Falls Over 9%
Stock News  ·  09-28 23:22
Optical Communication Stocks Decline Broadly as Credo Technology Falls Over 9%
Credo Technology Group Holding Ltd Rallies on AI Hopes
TIPRANKS  ·  09-26
Credo Technology Group Holding Ltd Rallies on AI Hopes
Vertiv and 6 More AI Industrial Stocks to Buy Now
Dow Jones  ·  09-25
Vertiv and 6 More AI Industrial Stocks to Buy Now
Wells Fargo Initiates Vertiv Holdings at Overweight With $340 Price Target
MT Newswires Live  ·  09-25
Wells Fargo Initiates Vertiv Holdings at Overweight With $340 Price Target
Vertiv initiated with an Overweight at Wells Fargo
TIPRANKS  ·  09-25
Vertiv initiated with an Overweight at Wells Fargo
Vertiv Strengthens AI Portfolio with King Environmental Services Deal; Why Is VRT Stock Falling Today?
TIPRANKS  ·  09-25
Vertiv Strengthens AI Portfolio with King Environmental Services Deal; Why Is VRT Stock Falling Today?
AnaptysBio Price Target Maintained with a $95.00/Share by HC Wainwright & Co.
Dow Jones  ·  09-24
AnaptysBio Price Target Maintained with a $95.00/Share by HC Wainwright & Co.
Vertiv to acquire King Environmental Services, terms not disclosed
TIPRANKS  ·  09-24
Vertiv to acquire King Environmental Services, terms not disclosed
Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Travere Therapeutics (TVTX) and Veeva Systems (VEEV)
TIPRANKS  ·  09-24
Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Travere Therapeutics (TVTX) and Veeva Systems (VEEV)
Top Executive Makes Major Move With Insider Stock Sale at Credo Technology
TIPRANKS  ·  09-24
Top Executive Makes Major Move With Insider Stock Sale at Credo Technology
AnaptysBio is Maintained at Outperform by Leerink Partners
Dow Jones  ·  09-23
AnaptysBio is Maintained at Outperform by Leerink Partners
Travere Therapeutics Receives US Patent Allowance for Kidney Disease Drug FILSPARI
MT Newswires Live  ·  09-23
Travere Therapeutics Receives US Patent Allowance for Kidney Disease Drug FILSPARI
Travere Therapeutics receives notice of allowance for FILSPARI patent
TIPRANKS  ·  09-23
Travere Therapeutics receives notice of allowance for FILSPARI patent
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)
TIPRANKS  ·  09-23
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)
TIPRANKS  ·  09-22
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)
Travere Therapeutics: Buy Rating Reiterated as CEO Transition Seen as Non-Disruptive, $67 Price Target Unchanged
TIPRANKS  ·  09-22
Travere Therapeutics: Buy Rating Reiterated as CEO Transition Seen as Non-Disruptive, $67 Price Target Unchanged
Travere Therapeutics Price Target Maintained with a $67.00/Share by HC Wainwright & Co.
Dow Jones  ·  09-22
Travere Therapeutics Price Target Maintained with a $67.00/Share by HC Wainwright & Co.
Option Focus | Credo Technology's $6.85 Million Dual Short Call Spread Collects Premium While Betting Upside Stays Capped Through 2026
Option Witch  ·  09-22
Option Focus | Credo Technology's $6.85 Million Dual Short Call Spread Collects Premium While Betting Upside Stays Capped Through 2026
Travere Therapeutics appoints new CEO Bradley Campbell
TIPRANKS  ·  09-22
Travere Therapeutics appoints new CEO Bradley Campbell

Introduction

Company Name.
Innovator IBD 50 ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.
Issue price:
--